Filgrastim and lenograstim both necessitate daily injections to impact neutropenia, while pegfilgrastim is a pegylated G-CSF and eflapegrastim is a pegylated IgG4 FC fusion protein, both administered once-per chemotherapy cycle, typically 24 h after chemotherapy treatment. This evidence concerns the gene CSF3 and Decreased total neutrophil count.